BioMarin Pharmaceutical (BMRN)
(Delayed Data from NSDQ)
$89.05 USD
+0.42 (0.47%)
Updated Apr 22, 2024 11:56 AM ET
After-Market: $89.25 +0.20 (0.22%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
04/24/2024
Time: AMC |
3/2024 | $0.60 | 21.30% |
Earnings Summary
For their last quarter, BioMarin Pharmaceutical (BMRN) reported earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.44 per share. This reflects a positive earnings surprise of 11.36%. Look out for BMRN's next earnings release on April 24, 2024. For the next earning release, we expect the company to report earnings of $0.60 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for BMRN
Novartis (NVS) to Report Q1 Earnings: What to Expect?
BMRN: What are Zacks experts saying now?
Zacks Private Portfolio Services